Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Change in Account Payables (2019 - 2026)

Pliant Therapeutics has reported Change in Account Payables over the past 8 years, most recently at -$118000.0 for Q1 2026.

  • Quarterly Change in Account Payables rose 65.09% to -$118000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$5.3 million through Mar 2026, down 350.73% year-over-year, with the annual reading at -$5.5 million for FY2025, 483.75% down from the prior year.
  • Change in Account Payables was -$118000.0 for Q1 2026 at Pliant Therapeutics, down from -$3000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $3.7 million in Q3 2024 and troughed at -$4.2 million in Q2 2025.
  • The 5-year median for Change in Account Payables is -$118000.0 (2026), against an average of -$150117.6.
  • Year-over-year, Change in Account Payables crashed 2163.16% in 2022 and then skyrocketed 1936.54% in 2023.
  • A 5-year view of Change in Account Payables shows it stood at -$1.6 million in 2022, then soared by 173.02% to $1.2 million in 2023, then crashed by 179.35% to -$930000.0 in 2024, then surged by 99.68% to -$3000.0 in 2025, then tumbled by 3833.33% to -$118000.0 in 2026.
  • Per Business Quant, the three most recent readings for PLRX's Change in Account Payables are -$118000.0 (Q1 2026), -$3000.0 (Q4 2025), and -$897000.0 (Q3 2025).